Curadev and Bayer agreement shows switch in gears towards STING antagonists, says GlobalData EP News Bureau Apr 16, 2020 Together, the companies will develop new drugs for lung disease, cardiovascular disease and other inflammatory diseases. In 2019,…
Curadev and Bayer agreement shows switch in gears towards STING antagonists: GlobalData EP News Bureau Apr 16, 2020 Globally, there are 42 STING agonists and 8 STING antagonists under development.
Bayer and Curadev sign research collaboration and license agreement to develop novel STING… EP News Bureau Mar 23, 2020 The collaboration aims to discover new drug candidates for the treatment of lung diseases, cardiovascular diseases and other…
